JP2023527049A5 - - Google Patents
Info
- Publication number
- JP2023527049A5 JP2023527049A5 JP2022572753A JP2022572753A JP2023527049A5 JP 2023527049 A5 JP2023527049 A5 JP 2023527049A5 JP 2022572753 A JP2022572753 A JP 2022572753A JP 2022572753 A JP2022572753 A JP 2022572753A JP 2023527049 A5 JP2023527049 A5 JP 2023527049A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- fewer
- residues
- amino acid
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2007842.4A GB202007842D0 (en) | 2020-05-26 | 2020-05-26 | Polypeptide useful in adoptive cell therapy |
| GB2007842.4 | 2020-05-26 | ||
| PCT/EP2021/064053 WO2021239812A1 (en) | 2020-05-26 | 2021-05-26 | Polypeptide useful in adoptive cell therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023527049A JP2023527049A (ja) | 2023-06-26 |
| JP2023527049A5 true JP2023527049A5 (https=) | 2024-05-29 |
Family
ID=71406309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022572753A Pending JP2023527049A (ja) | 2020-05-26 | 2021-05-26 | 養子細胞療法に有用なポリペプチド |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230183311A1 (https=) |
| EP (1) | EP4157318A1 (https=) |
| JP (1) | JP2023527049A (https=) |
| CN (1) | CN115955977A (https=) |
| AU (1) | AU2021279184A1 (https=) |
| CA (1) | CA3179441A1 (https=) |
| GB (2) | GB202007842D0 (https=) |
| TW (1) | TW202210503A (https=) |
| WO (1) | WO2021239812A1 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7436383B2 (ja) | 2018-04-18 | 2024-02-21 | ユーシーエル ビジネス リミテッド | 操作された調節性ｔ細胞 |
| TW202321286A (zh) | 2021-09-21 | 2023-06-01 | 英商圭爾醫療有限公司 | 抗p75ntr嵌合抗原受體 |
| EP4405385A1 (en) | 2021-09-21 | 2024-07-31 | Quell Therapeutics Limited | Anti-trem2 chimeric antigen receptor |
| GB202117298D0 (en) | 2021-11-30 | 2022-01-12 | Quell Therapeutics Ltd | Signalling protein |
| US20250017967A1 (en) | 2021-12-17 | 2025-01-16 | Quell Therapeutics Limited | Anti-thymocyte globulin for immunomodulation of a subject with regulatory t cells |
| EP4453022A1 (en) | 2021-12-22 | 2024-10-30 | Quell Therapeutics Limited | Constitutive cytokine receptors |
| EP4496883A1 (en) | 2022-03-22 | 2025-01-29 | Quell Therapeutics Limited | Methods and products for culturing t cells and uses thereof |
| JP2025515134A (ja) * | 2022-05-04 | 2025-05-13 | アーリ インコーポレイテッド | 疾患細胞の位置を決定するおよび／または疾患細胞を処置するために表面発現可能な活性化可能エピトープを使用する方法 |
| GB202217541D0 (en) | 2022-11-24 | 2023-01-11 | Quell Therapeutics Ltd | Recombinant receptor |
| WO2024133472A1 (en) | 2022-12-22 | 2024-06-27 | Quell Therapeutics Limited | Constitutive cytokine receptors |
| EP4403580A1 (en) | 2023-01-23 | 2024-07-24 | Medizinische Hochschule Hannover | Anti-entpd3 chimeric antigen receptor |
| CN120981484A (zh) | 2023-01-23 | 2025-11-18 | 汉诺威医学院 | 抗entpd3嵌合抗原受体 |
| AU2024219048A1 (en) | 2023-02-07 | 2025-08-07 | Quell Therapeutics Limited | Culture method for treg cells |
| WO2024175805A1 (en) | 2023-02-24 | 2024-08-29 | Medizinische Hochschule Hannover | Chimeric antigen receptor |
| EP4420676A1 (en) | 2023-02-24 | 2024-08-28 | Medizinische Hochschule Hannover | Chimeric antigen receptor |
| EP4434539A1 (en) | 2023-03-20 | 2024-09-25 | Medizinische Hochschule Hannover | Chimeric antigen receptor |
| WO2024194355A1 (en) | 2023-03-20 | 2024-09-26 | Medizinische Hochschule Hannover | Chimeric antigen receptor |
| WO2024194649A1 (en) | 2023-03-22 | 2024-09-26 | Quell Therapeutics Limited | Engineered t cells and uses thereof |
| WO2024194642A1 (en) | 2023-03-22 | 2024-09-26 | Quell Therapeutics Limited | Engineered t regulatory cell |
| EP4442322A1 (en) | 2023-04-06 | 2024-10-09 | Medizinische Hochschule Hannover | Liver-specific car for use against immunologic rejection |
| CN121586727A (zh) | 2023-06-21 | 2026-02-27 | 圭尔医疗有限公司 | 组成型细胞因子受体 |
| EP4512415A1 (en) | 2023-08-24 | 2025-02-26 | Medizinische Hochschule Hannover | Chimeric antigen receptor for treatment of multiple sclerosis or alzheimer's disease |
| WO2025040799A1 (en) | 2023-08-24 | 2025-02-27 | Medizinische Hochschule Hannover | Car for treatment of ms or ad |
| WO2026008994A1 (en) | 2024-07-04 | 2026-01-08 | Quell Therapeutics Limited | Expression construct |
| EP4678187A1 (en) | 2024-07-11 | 2026-01-14 | Medizinische Hochschule Hannover | Compound for use in the treatment of inflammatory bowel disease |
| WO2026027876A1 (en) | 2024-07-29 | 2026-02-05 | Quell Therapeutics Limited | Chimeric antigen receptor |
| GB202411558D0 (en) | 2024-08-06 | 2024-09-18 | Quell Therapeutics Ltd | Culture method |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0752248T3 (da) | 1992-11-13 | 2000-11-13 | Idec Pharma Corp | Terapeutisk anvendelse af kimæriske og radioaktivt mærkede antistoffer mod humant B-lymfocytbegrænset differentieringsantig |
| US5736137A (en) | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| JP2007515946A (ja) | 2003-06-13 | 2007-06-21 | オンコマックス アクイジション コーポレイション | 抗腫瘍二元機能融合タンパク質の調製および適用 |
| NZ544924A (en) | 2003-06-27 | 2009-03-31 | Biogen Idec Inc | Modified binding molecules comprising connecting peptides |
| BRPI0610203A2 (pt) | 2005-05-24 | 2010-06-01 | Avestha Gengraine Tech Pvt Ltd | processo de preparação in vivo de anti-corpo monoclonal anti-cd 20 biologicamente ativo e composição farmacêutica |
| GB201206559D0 (en) * | 2012-04-13 | 2012-05-30 | Ucl Business Plc | Polypeptide |
| GB201415344D0 (en) * | 2014-08-29 | 2014-10-15 | Ucl Business Plc | Protein |
| BR112017013981A2 (pt) * | 2015-01-26 | 2018-01-02 | Cellectis | receptores antigênicos quiméricos com uma única cadeia específicos anti-cll1 (sccars) para imunoterapia de câncer |
| US10294304B2 (en) * | 2015-04-13 | 2019-05-21 | Pfizer Inc. | Chimeric antigen receptors targeting B-cell maturation antigen |
| US10604586B2 (en) | 2016-05-09 | 2020-03-31 | Industrial Technology Research Institute | Humanized monoclonal antibody and uses thereof |
| AU2018246377B2 (en) * | 2017-03-31 | 2025-01-30 | Cellectis Sa | Universal anti-CD22 chimeric antigen receptor engineered immune cells |
| AU2019250692A1 (en) * | 2018-04-13 | 2020-11-05 | Sangamo Therapeutics France | Chimeric antigen receptor specific for Interleukin-23 receptor |
| CN112996819B (zh) * | 2018-08-16 | 2025-11-04 | 纪念斯隆-凯特琳癌症中心 | 细胞分选系统及使用方法 |
| GB201814203D0 (en) | 2018-08-31 | 2018-10-17 | King S College London | Engineered regulatory t cell |
-
2020
- 2020-05-26 GB GBGB2007842.4A patent/GB202007842D0/en not_active Ceased
-
2021
- 2021-05-26 JP JP2022572753A patent/JP2023527049A/ja active Pending
- 2021-05-26 WO PCT/EP2021/064053 patent/WO2021239812A1/en not_active Ceased
- 2021-05-26 AU AU2021279184A patent/AU2021279184A1/en active Pending
- 2021-05-26 GB GB2218768.6A patent/GB2611448B/en active Active
- 2021-05-26 TW TW110118988A patent/TW202210503A/zh unknown
- 2021-05-26 EP EP21728234.2A patent/EP4157318A1/en active Pending
- 2021-05-26 CN CN202180047478.8A patent/CN115955977A/zh active Pending
- 2021-05-26 CA CA3179441A patent/CA3179441A1/en active Pending
- 2021-05-26 US US17/926,374 patent/US20230183311A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023527049A5 (https=) | ||
| GB2611448A (en) | Polypeptide useful in adoptive cell therapy | |
| AU2018298881B2 (en) | Improved dual specificity polypeptide molecule | |
| KR102174280B1 (ko) | 키메라 항원 수용체 | |
| EP3472205B1 (en) | Chimeric antigen receptor | |
| AU2019205273B2 (en) | Multi-domain immunomodulatory proteins and methods of use thereof | |
| JP6936497B2 (ja) | 多価Ｆｖ抗体 | |
| JP2022534680A5 (https=) | ||
| JP2017527310A5 (https=) | ||
| KR20220025698A (ko) | 다기능 융합 단백질 및 이의 용도 | |
| JP2022545815A5 (https=) | ||
| CN111801347A (zh) | Ctla-4变体免疫调节蛋白和其用途 | |
| JP2024534783A5 (https=) | ||
| RU2815388C2 (ru) | Многофункциональные слитые белки и их применения | |
| HK40071054A (en) | Improved dual specificity polypeptide molecule | |
| CN121986120A (en) | Bispecific polypeptide molecules | |
| WO2022026577A4 (en) | Chimeric t cell receptors, nucleic acids, and methods of making and using the same | |
| HK40003407B (en) | Improved dual specificity polypeptide molecule | |
| HK40003407A (en) | Improved dual specificity polypeptide molecule | |
| HK40029654A (en) | Improved dual specificity polypeptide molecule | |
| HK40029654B (en) | Improved dual specificity polypeptide molecule | |
| IL272045B2 (en) | A polypeptide molecule with dual-purpose specificity |